Mimedx (MDXG) Retained Earnings (2016 - 2025)
Historic Retained Earnings for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to -$57.9 million.
- Mimedx's Retained Earnings rose 4136.4% to -$57.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$57.9 million, marking a year-over-year increase of 4136.4%. This contributed to the annual value of -$91.3 million for FY2024, which is 3173.22% up from last year.
- Mimedx's Retained Earnings amounted to -$57.9 million in Q3 2025, which was up 4136.4% from -$74.6 million recorded in Q2 2025.
- Over the past 5 years, Mimedx's Retained Earnings peaked at -$57.9 million during Q3 2025, and registered a low of -$196.9 million during Q1 2023.
- Moreover, its 5-year median value for Retained Earnings was -$161.6 million (2021), whereas its average is -$144.1 million.
- As far as peak fluctuations go, Mimedx's Retained Earnings tumbled by 4940.59% in 2021, and later soared by 4726.46% in 2024.
- Over the past 5 years, Mimedx's Retained Earnings (Quarter) stood at -$161.7 million in 2021, then decreased by 18.67% to -$191.9 million in 2022, then skyrocketed by 30.34% to -$133.7 million in 2023, then soared by 31.73% to -$91.3 million in 2024, then soared by 36.58% to -$57.9 million in 2025.
- Its Retained Earnings was -$57.9 million in Q3 2025, compared to -$74.6 million in Q2 2025 and -$84.2 million in Q1 2025.